174 related articles for article (PubMed ID: 3785155)
21. Fibroblast immortality is a prerequisite for transformation by EJ c-Ha-ras oncogene.
Newbold RF; Overell RW
Nature; 1983 Aug 18-24; 304(5927):648-51. PubMed ID: 6877385
[TBL] [Abstract][Full Text] [Related]
22. Multistep carcinogenesis of normal human fibroblasts. Human fibroblasts immortalized by repeated treatment with Co-60 gamma rays were transformed into tumorigenic cells with Ha-ras oncogenes.
Namba M; Nishitani K; Fukushima F; Kimoto T
Anticancer Res; 1988; 8(5A):947-58. PubMed ID: 3140712
[TBL] [Abstract][Full Text] [Related]
23. Suppression of tumorigenicity in hybrids of normal and oncogene-transformed CHEF cells.
Craig RW; Sager R
Proc Natl Acad Sci U S A; 1985 Apr; 82(7):2062-6. PubMed ID: 3856884
[TBL] [Abstract][Full Text] [Related]
24. Different activities of the adenovirus types 5 and 12 E1A regions in transformation with the EJ Ha-ras oncogene.
Jochemsen AG; Bernards R; van Kranen HJ; Houweling A; Bos JL; van der Eb AJ
J Virol; 1986 Sep; 59(3):684-91. PubMed ID: 3735492
[TBL] [Abstract][Full Text] [Related]
25. Human oncogene-transfected tumor cells display differential susceptibility to lysis by lymphokine-activated killer cells (LAK) and natural killer cells.
Lanza LA; Wilson DJ; Ikejiri B; Roth JA; Grimm EA
J Immunol; 1986 Oct; 137(8):2716-20. PubMed ID: 3489774
[TBL] [Abstract][Full Text] [Related]
26. Chromosome losses in tumorigenic revertants of EJ/ras-expressing somatic cell hybrids.
Pratt CI; Wu SQ; Bhattacharya M; Kao C; Gilchrist KW; Reznikoff CA
Cancer Genet Cytogenet; 1992 Apr; 59(2):180-90. PubMed ID: 1316224
[TBL] [Abstract][Full Text] [Related]
27. Evidence for multiple steps in neoplastic transformation of normal and preneoplastic Syrian hamster embryo cells following transfection with Harvey murine sarcoma virus oncogene (v-Ha-ras).
Thomassen DG; Gilmer TM; Annab LA; Barrett JC
Cancer Res; 1985 Feb; 45(2):726-32. PubMed ID: 2981612
[TBL] [Abstract][Full Text] [Related]
28. The int-1 proto-oncogene is transcriptionally activated during neuroectodermal differentiation of P19 mouse embryonal carcinoma cells.
St-Arnaud R; Craig J; McBurney MW; Papkoff J
Oncogene; 1989 Sep; 4(9):1077-80. PubMed ID: 2674852
[TBL] [Abstract][Full Text] [Related]
29. Differential expression of jun and fos genes during differentiation of mouse P19 embryonal carcinoma cells.
de Groot RP; Schoorlemmer J; van Genesen ST; Kruijer W
Nucleic Acids Res; 1990 Jun; 18(11):3195-202. PubMed ID: 2113273
[TBL] [Abstract][Full Text] [Related]
30. Normal human mesothelial cells and fibroblasts transfected with the EJras oncogene become EGF-independent, but are not malignantly transformed.
Tubo RA; Rheinwald JG
Oncogene Res; 1987; 1(4):407-21. PubMed ID: 3130603
[TBL] [Abstract][Full Text] [Related]
31. Activated Ki-ras genes in bladder epithelial cell lines transformed by treatment of primary mouse bladder explant cultures with 7,12-dimethylbenz[a]anthracene.
Brookes P; Cooper CS; Ellis MV; Warren W; Gardner E; Summerhayes IC
Mol Carcinog; 1988; 1(2):82-8. PubMed ID: 3151261
[TBL] [Abstract][Full Text] [Related]
32. Loss of platelet-derived growth factor-stimulated phospholipase activity in NIH-3T3 cells expressing the EJ-ras oncogene.
Benjamin CW; Tarpley WG; Gorman RR
Proc Natl Acad Sci U S A; 1987 Jan; 84(2):546-50. PubMed ID: 3099298
[TBL] [Abstract][Full Text] [Related]
33. Reduced hormone-stimulated adenylate cyclase activity in NIH-3T3 cells expressing the EJ human bladder ras oncogene.
Tarpley WG; Hopkins NK; Gorman RR
Proc Natl Acad Sci U S A; 1986 Jun; 83(11):3703-7. PubMed ID: 3012529
[TBL] [Abstract][Full Text] [Related]
34. Activating missense mutations in Ha-ras-1 genes in a malignant subset of bladder lesions induced by N-butyl-N-(4-hydroxybutyl)nitrosamine or N-[4-(5-nitro-2-furanyl)-2-thiazolyl]formamide.
Jones RF; Debiec-Rychter M; Zukowski K; Wang CY
Mol Carcinog; 1990; 3(6):393-402. PubMed ID: 2278634
[TBL] [Abstract][Full Text] [Related]
35. Transient expression of the proto-oncogene int-1 during differentiation of P19 embryonal carcinoma cells.
Schuuring E; van Deemter L; Roelink H; Nusse R
Mol Cell Biol; 1989 Mar; 9(3):1357-61. PubMed ID: 2657391
[TBL] [Abstract][Full Text] [Related]
36. Expression of hepatocyte and oval cell antigens in hepatocellular carcinomas produced by oncogene-transfected liver epithelial cells.
Goyette M; Faris R; Braun L; Hixson D; Fausto N
Cancer Res; 1990 Aug; 50(15):4809-17. PubMed ID: 2196118
[TBL] [Abstract][Full Text] [Related]
37. Regulated expression of Wnt family members during neuroectodermal differentiation of P19 embryonal carcinoma cells: overexpression of Wnt-1 perturbs normal differentiation-specific properties.
Smolich BD; Papkoff J
Dev Biol; 1994 Nov; 166(1):300-10. PubMed ID: 7958454
[TBL] [Abstract][Full Text] [Related]
38. Altered growth properties and cell surface changes in ras transformed mouse bladder epithelium.
Summerhayes IC; Malone P; Visvanathan K
Int J Cancer; 1986 Feb; 37(2):233-40. PubMed ID: 3002989
[TBL] [Abstract][Full Text] [Related]
39. Transformation of human bronchial epithelial cells transfected by Harvey ras oncogene.
Yoakum GH; Lechner JF; Gabrielson EW; Korba BE; Malan-Shibley L; Willey JC; Valerio MG; Shamsuddin AM; Trump BF; Harris CC
Science; 1985 Mar; 227(4691):1174-9. PubMed ID: 3975607
[TBL] [Abstract][Full Text] [Related]
40. Neoplastic progression by EJ/ras at different steps of transformation in vitro of human uroepithelial cells.
Pratt CI; Kao CH; Wu SQ; Gilchrist KW; Oyasu R; Reznikoff CA
Cancer Res; 1992 Feb; 52(3):688-95. PubMed ID: 1310069
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
